C. Su, H. Chai, Y. See, and R. S. Kumar, “GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF SGLT2 INHIBITORS (EMPAGLIFLOZIN 25 MG, EMPAGLIFLOZIN 12.5 MG AND DAPAGLIFLOZIN 10 MG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: A SINGLE CENTRE STUDY”, J ASEAN Fed Endocr Soc, vol. 39, no. S1, p. 25, Jul. 2024.